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Drug resistanceIsoniazid (INH) susceptibility testing for 100 Mycobacterium tuberculosis performed by con-
ventional minimum inhibitory concentration (MIC) method was stratified using additional
drug concentrations. Introduction of additional drug concentrations did not greatly
improve the discriminatory capacity, but can be used in specialized studies pertaining to
cross resistance between structural analogues of INH.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Isoniazid (INH) is considered a vital drug in the treatment attempt to identify cross resistance between these drugsof tuberculosis (TB) [1]. The mechanism of INH action on
Mycobacterium tuberculosis is narrowed down to mycolic acid
synthesis in the cell wall. Molecular studies on INH indicated
the involvement of katG and inhA genes playing a major role
in resistance [2]. Phenotypic and genotypic methods for drug
susceptibility testing (DST) have been well evaluated for INH.
Similarity in structure and cellular target of INH and
ethionamide (ETO) has led to the phenomenon of cross resis-
tance between these drugs. It is reported that low level INH
resistant isolates are likely to be ETO resistant [3–5]. An earlierindicated the need for revisiting DST for INH [6]. Though the
conventional minimum inhibitory concentration (MIC)
method on solid Lowenstein-Jensen (LJ) medium for INH is a
time-tested procedure, there lies a vast difference between
the drug concentrations used for defining the susceptibility
profile [7]. To classify the low level of INH resistance more
precisely, susceptibility testing was carried out using drug
concentrations ranging in-between the existing concentra-
tions used in the MIC method.aar Nagar,
Table 1 – Comparison of susceptibility of INH by conventional and modified MIC methods.
Modified MIC method Conventional MIC method
Susceptible
(at MIC 60.2 lg/ml)
Low level Resistant
(at MIC 1.0 lg/ml)
Resistant
(at MIC P5.0 lg/ml)
Total
60.2 lg/ml 44 2 2 48
0.5 lg/ml 1 7 0 8
1.0 lg/ml 2 4 3 9
3.0 lg/ml 0 0 6 6
P5.0 lg/ml 0 0 29 29
Total 47 13 40 100
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isolates was performed by the conventional MIC method
following standard operating procedures [8]. In addition to
the existing INH concentrations, 0.2, 1.0 and 5.0 lg/ml, and
two more intermediary INH concentrations, namely 0.5 and
3.0 lg/ml, were introduced as a modification, and the isolates
were subjected to retesting by the modified method. Standard
interpretation was followed for conventional MICmethod and
isolates with an MIC of 0.5 lg/ml were considered as suscep-
tible and 3.0 lg/ml as resistant, respectively.
Among the 100 M. tuberculosis isolates analyzed by conven-
tional MIC method, 47% and 40% were susceptible and resis-
tant towards INH. Borderline resistance (MIC of 1.0 lg/ml)
was observed in 13% of the isolates. Including additional
INH concentration in modified MIC method, 48% and 29%
showed susceptible and resistant profile (Table 1). Borderline
resistance with MIC of 1.0 lg/ml was observed with 9% of iso-
lates. MIC of 0.5 lg/ml and 3.0 lg/ml was exhibited by 8% and
6% of the isolates, respectively. Comparison of both the MIC
methods indicated that 7 of 13 borderline isolates (with MIC
of 1.0 lg/ml) in conventional MIC method exhibited a MIC of
0.5 lg/ml by modified MIC method. Among the 47 susceptible
isolates by conventional MIC method, only 3 were discrepant
by the modified method; wherein, a single isolate had a MIC
of 0.5 lg/ml, and 2 showed borderline resistance with a MIC
of 1.0 lg/ml. Within the resistant category in conventional
MIC method, 3 and 2 isolates exhibited borderline resistant
and susceptible phenotypes by modified MIC method, and 6
isolates had a MIC of 3.0 lg/ml by modified MIC method.
Resistance to INH has become a frequent observation
among all drug resistant clinical isolates, with incidence as
high as 20% to 30% in some regions [9]. Phenotypic DST in
solid LJ medium and in MGIT 960 liquid culture systems are
routinely used in laboratories across the world for the detec-
tion of INH resistance [10]. An attempt to detect low level INH
resistance (phenotypic) was novel and was hypothesized to
provide substantial evidence for cross-resistance between
INH and ETO. With the introduction of additional INH concen-
trations, it was evident that isolates exhibiting borderline
resistance are tricky to interpret as they may indicate either
of the phenotypes upon repeat testing. None of the borderline
isolates upon retesting showed a MIC of 3.0 lg/ml, again reit-
erating the fact that borderline isolates have a tendency to
shift towards susceptible phenotype. Another explanation
could be that the ratio of resistant and susceptible isolates
should be near equal, and phenotypes of the dominant clonesare portrayed. Presence of borderline phenotypes among the
susceptible isolates could also be due to the above phenome-
non. The two resistant isolates that showed susceptible phe-
notype by modified method had low colony counts, and the
discrepancy could be due to technical error.
Overall, the existing INH concentrations used in MIC
method can be continued as standard format for INH suscep-
tibility testing. The attempt to classify low level INH resis-
tance using additional INH concentrations though could not
completely distinguish borderline INH resistant isolates; it
had substantially classified a large proportion of them as sus-
ceptible. Validity of these results can be confirmed by molec-
ular identification. Modified MIC method for the detection of
low level INH resistance could be used only to resolve the re-
sults obtained in studies on cross-resistance between INH
and its structural analogues.
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